Heterologous Expression of Mouse Cytochrome P450 2e1 in V79 Cells: Construction and Characterisation of the Cell Line and Comparison with V79 Cell Lines Stably Expressing Rat P450 2E1 and Human P450 2E1
Restricted accessResearch articleFirst published online January, 2003
Heterologous Expression of Mouse Cytochrome P450 2e1 in V79 Cells: Construction and Characterisation of the Cell Line and Comparison with V79 Cell Lines Stably Expressing Rat P450 2E1 and Human P450 2E1
A V79 Chinese hamster cell line was constructed for stable expression of mouse cytochrome P450 2e1 (Cyp2e1), as an addition to the existing cell battery consisting of cell lines stably expressing rat CYP2E1 and human CYP2E1 (V79 Cell Battery™). The aim was to establish a cell battery that offers the in vitro possibility of investigating species-specific differences in the toxicity and metabolism of chemicals representing substrates for CYP2E1. The newly established cell line (V79m2E1) effectively expressed Cyp2e1 in the catalytically active form. The expression of catalytically active CYP2E1 in V79m2E1 cells was maintained over several months in culture, as demonstrated by Western Blotting and chlorzoxazone (CLX) 6-hydroxylase activity. The cells exhibited CLX 6-hydroxylase activity with a Km of 27.8μM/l and Vmax of 40pmol/mg protein/minute, compared with a Km of 28.2/28.6μM/l and a Vmax of 130/60pmol/mg protein/minute from V79r2E1/V79h2E1 cells. Furthermore, the CYP2E1-dependent mutagenicity of N-nitrosodimethylamine could be demonstrated in the V79m2E1 cells. Therefore, the new cell battery permits the interspecies comparison of CYP2E1-dependent toxicity and of metabolism of chemicals between humans and the two major rodent species — the rat and the mouse — that are usually used in classical toxicity studies.
GuengerichF.P., KimD., & IwasakiM. (1991). Role of human P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chemical Research in Toxicology4, 168–179.
2.
KoopD.R. (1992). Oxidative and reductive metabolism by cytochrome P450 2E1. The FASEB Journal6, 724–730.
3.
LieberC.S. (1997). Cytochrome P-4502E1: its physiological and pathological role. Physiological Reviews77, 517–544.
4.
RendicS., & Di CarloF.J. (1997). Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metabolism Reviews29, 413–580.
5.
DoehmerJ., ButersJ.T.M., LuchA., SoballaV., BairdW.M., MorissonH., StegemannJ.J., TownsendA.J., GreenleeW.F., GlattH.R., SeidelA., JacobJ., & GreimH. (1999). Molecular studies on the toxifying effects by genetically engineered cytochromes P450. Drug Metabolism Reviews31, 423–435.
6.
CrespiC.L., LangenbachR., & PenmanB.W. (1993). Human cell lines, derived from AHH-1 TK+/- human lymphoblasts, genetically engineered for expression of cytochromes P450. Toxicology82, 89–104.
7.
CrespiC.L., PenmanB.W., GonzalezF.J., GelboinH.V., GalvinM., & LangenbachR. (1993). Genetic toxicology using human cell lines expressing human P-450. Biochemical Society Transactions21, 1023–1028.
8.
DoehmerJ., & JacobJ. (1994). Genetically engineered V79 cell lines in combination with analytical-chemical procedures for replacing and refining animal experimentations. Alternativen zu Tierexperimenten11, 141–147.
SchmalixW.A., BarrenscheenM., LandsiedelR., JanzowskiC., EisenbrandG., GonzalezF., EliassonE., Ingelmann-SundbergM., PerchermeierM., GreimH., & DoehmerJ. (1995). Stable expression of human cytochrome P450 2E1 in V79 Chinese hamster cells. European Journal of Pharmacology293, 123–131.
11.
ArteltP., MorelleC., AusmeierM., FitzekM., & HauserH. (1988). Vectors for efficient expression in mammalian fibroblastoid, myeloid and lymphoid cells via transfection or infection. Gene68, 213–219.
12.
GlattH.R., GemperleinI., SetiabudiF., PlattK.L., & OeschF. (1990). Expression of xenobiotic-metabolising enzymes in propagatable cell cultures and induction of micronuclei by 13 compounds. Mutagenesis5, 241–249.
13.
DoehmerJ., & OeschF (1991). V79 Chinese hamster cells genetically engineered for stable expression of cytochromes P450. Methods in Enzymology206, 17–123.
14.
BradfordM.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein–dye binding. Analytical Biochemistry72, 248–254
15.
LaemmliU.K. (1970). Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature227, 680–685.
16.
MatsubaraT., KoikeM., TouchiA., TochinoY., & SugenoK. (1976). Quantitative determination of cytochrome P-450 in rat liver homogenate. Analytical Biochemistry75, 569–603.
17.
RuttenA.A.J.J.L., FalkeH., CatsburgJ., ToppR., BlaauboerB., van HolsteijnI., DoornL., & van LeeuwenR. (1987). Interlaboratory comparison of total cytochrome P-450 and protein determinations in rat liver microsomes. Archives of Toxicology61, 27–33.
18.
GlattH.R., PieeA., PaulyK., SteinbrecherT., SchrodeR., OeschF., & SeidelA. (1991). Fjord- and bay region diol-epoxides investigated on stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells. Cancer Research51, 1659–1667.
19.
PeterR., BöckerR., BeauneP.H., IxasakiM., GuengerichF.P., & YangC.S. (1990). Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chemical Research in Toxicology3, 566–573.
20.
OmuraT., & SatoR. (1964). The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry239, 2370–2378.
21.
LinH., RobertsE.S., & HollenbergP.F. (1998). Heterologous expression of rat P450 2E1 in a mammalian cell line: in situ metabolism and cytotoxicity of N-nitrosodimethylamine. Carcinogenesis19, 321–329.
22.
JacobJ., DoehmerJ., GrimmerG., SoballaV., RaabG., SeidelA., & GreimH. (1996). Metabolism of phenanthrene, benz[a]anthracene, benzo[a]pyrene, chrysene and benzo[c]phenanthrene by eight cDNA-expressed human and rat cytochromes P450. Polycyclic Aromatic Compounds10, 1–9.
23.
JacobJ., RaabG., SoballaV., SchmalixW.A., GrimmerG., GreimH., DoehmerJ., & SeidelA. (1996). Cytochrome P450 mediated activation of phenanthrene in genetically engineered V79 hamster cells. Environmental Toxicology and Pharmacology1, 1–11.
24.
ValentineJ.L., LeeS.S.T., SeatonM.J., AsgharianB., FarrisG., CortonJ.C., GonzalesF.J., & MedinskyM. (1996). Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicology and Applied Pharmacology14, 205–213.
25.
HendersonR.F., SabourinP.J., BechtoldW.E., GriffithW.D., MedinskyM.A., BirnbaumL.S., & LucierG. (1989). The effect of dose, dose rate, route of administration, and species on tissue and blood levels of benzene metabolites. Environmental Health Perspectives82, 9–17.
26.
ProutM.S., ProvanW.M., & GreenT. (1985). Species specific differences in response to trichloroethylene. Toxicology and Applied Pharmacology79, 389–400.
27.
SongB., GelboinH.V., ParkS., YangC.S., & GonzalezF.J. (1986). Complementary DNA and protein sequences of ethanol inducible rat and human cytochrome P-450s. Journal of Biological Chemistry261, 16689–16697.
28.
FreemanJ.E., StirlingD., RusselA.L., & WolfC.R. (1992). cDNA sequence, deduced amino acid sequence, predicted gene structure and chemical regulation of mouse Cyp2e1. Biochemical Journal281, 689–695.
